Atlas Trials

Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy

Clinical trial NCT06172088 · COMPLETED

Trial details

NCT number
NCT06172088
Sponsor
University Hospital Tuebingen
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer Patients Treated With Aromatase Inhibitors
Start date
2023-12-15
Primary completion
2024-12-30
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.